FDA cleared the ULSPIRA TS™ Nitric Oxide Therapy System from Airgas Therapeutics, LLC on Oct 30, 2026 under K253095, a traditional 510(k). The device falls under product code MRN, Apparatus, Nitric Oxide Delivery, regulated at 21 CFR 868.5165 as a Class 2 device. The review panel was Anesthesiology.

FDA logged the submission as received on Sep 23, 2025. The decision came 402 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.

This is the only decision on file for Airgas Therapeutics, LLC in the last 12 months of the tracker.